Zhipeng Yan

1.4k citations
35 papers · 1.1k indexed · h-index 21
Topics
Herpesvirus Infections and Treatments (9 papers)interferon and immune responses (7 papers)Hepatitis B Virus Studies (7 papers)

In The Last Decade

Zhipeng Yan

35 papers receiving 1.0k citations

Peers

Zhipeng Yan
Comparison fields: 5 of 75
  • Epidemiology 562
  • Immunology 413
  • Infectious Diseases 330
  • Molecular Biology 305
  • Hepatology 124
Replace Andrew M. Lee with:
Andrew M. Lee United States
Abhilash I. Chiramel United States
Nicholas J. Megjugorac United States
Anne Louise France
Susan M. Efler United States
Uma Kavita United States
Jane E. Allan Australia
H. L. Davis Canada
Syed M. Moin United States
Michiel van Gent Netherlands
Zhipeng Yan relative to Andrew M. Lee United States Andrew M. Lee's profile →
Citations per field
00.5×1.5×1.9×
Andrew M. Lee · 1×
Citations per year

Countries citing papers authored by Zhipeng Yan

Since Specialization
Citations

This map shows the geographic impact of Zhipeng Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhipeng Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhipeng Yan more than expected).

Fields of papers citing papers by Zhipeng Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhipeng Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhipeng Yan. The network helps show where Zhipeng Yan may publish in the future.

Co-authorship network of co-authors of Zhipeng Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhipeng Yan. A scholar is included among the top collaborators of Zhipeng Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhipeng Yan. Zhipeng Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 4
4 2
5 15
6 38
7 10
8 31
9 11
10 62
11 13
12 32
13 21
14 69
15 32
16 53
17 20
18 160
19 9
20
The variation of antigen expression: a natural phenomenon utilised for the construction of live recombinant Salmonella vaccines.
3

About Zhipeng Yan

Zhipeng Yan is a scholar working on Immunology, Epidemiology and Hepatology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (9 papers), interferon and immune responses (7 papers) and Hepatitis B Virus Studies (7 papers). The work is most often cited by research in Immunology (413 citations), Infectious Diseases (330 citations) and Epidemiology (562 citations). Zhipeng Yan has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Bin He, Yijie Ma, Zongdi Feng, Bin He, Songwang Hou, Lu Gao, Huali Jin, Youjia Cao, Hui Hu and Tibor Vályi-Nagy. Their work appears in journals such as Journal of Biological Chemistry, Hepatology and Journal of Hazardous Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026